inflammation

A unique collection of 4940 anti-inflammation compounds effective for high throughput screening and high content screening.

A unique collection of 540 gut microbial metabolites which can be used for HTS and HCS;

A unique collection of 3404 compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 517 flavonoids can be used for high throughput and high content screening；

609 non-steroidal anti-inflammatory compounds for high-throughput and high-content screening.

A unique collection of 4880 anti-aging compounds for high throughput screening (HTS) and high content screening (HCS);

A collection of 1279 TCM monomers with anti-inflammatory activity or targeting molecular therapeutic targets in inflammation, a powerful tool for drug discovery and mechanism study；

A unique collection of 622 natural terpenes and terpenoids can be used for high throughput and high content screening；

A unique collection of 219 natural products related to gastroenteritis for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 385 bioactive lipids related compounds for high throughput screening (HTS) and high content screening (HCS), including Agonists & Antagonists, Endocannabinoids, Farnesyl geranylgeranyl derivates, HETEs deHETEs, hepoxilins, Polyunsa